RUNX1 and acute myeloid leukemia: We confirmed the role of NCAM1 in resistance, particularly in RUNX1-RUNX1T1-rearranged AML, and identified interferon and inflammatory responses as critical to early resistance in NPM1mut cells, thereby deepening our understanding of transcriptional plasticity in BETi resistance14,16,22,47,61,62.